You have 9 free searches left this month | for more free features.

City

Guangzhou (1)

Condition

ALK Positive Non-small Cell Lung Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Guangdong Association of Clinical Trials (1)

Collaborator

Intervention

loratinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

loratinib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

ALK Positive NSCLC Trial in Guangzhou (Loratinib)

Recruiting

ALK Positive Non-small Cell Lung Cancer

Loratinib

Guangzhou, Guangdong, China

Guangdong Provincial Perople's Hospital

Oct 19, 2023